Sonoma Pharmaceuticals (SNOA) Prepaid Assets (2011 - 2025)
Sonoma Pharmaceuticals (SNOA) recorded quarterly Prepaid Assets of $3.4 million in Q4 2025, up 14.56% quarter-over-quarter from $2.9 million in Q3 2025, and up 141.6% on a YoY basis from $1.4 million in Q4 2024.
Sonoma Pharmaceuticals (SNOA) Prepaid Assets (2011 - 2025) Analysis & Trends
Sonoma Pharmaceuticals' Prepaid Assets history runs 15 years deep, the most recent figure standing at $3.4 million for Q4 2025.
- In Q4 2025, Prepaid Assets rose 141.6% year-over-year to $3.4 million; the TTM figure through Dec 2025 stood at $3.4 million (up 141.6% YoY), while the FY2025 annual figure was $1.9 million, up 1723.81% from the prior year.
- Prepaid Assets was $3.4 million for Q4 2025 at Sonoma Pharmaceuticals, up from $2.9 million in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $4.6 million in Q2 2023 to a low of $25000.0 in Q1 2023.
- Historically, Prepaid Assets has averaged $2.8 million across 5 years, with a median of $3.2 million in 2021.
- The sharpest annual moves came in 2023 and 2025: Prepaid Assets tumbled 95.97% in 2023, then surged 1723.81% in 2025.
- A 5-year view of Prepaid Assets shows it stood at $3.2 million in 2021, then rose by 0.12% to $3.2 million in 2022, then gained by 24.12% to $4.0 million in 2023, then slumped by 65.4% to $1.4 million in 2024, then surged by 141.6% to $3.4 million in 2025.
- The last three Prepaid Assets figures came in at $3.4 million (Q4 2025), $2.9 million (Q3 2025), and $2.9 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Sonoma Pharmaceuticals | 1.90 Mn | -659,569.98 | 1.65 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 3.35 Mn |
| Sep 30, 2025 | 2.93 Mn |
| Jun 30, 2025 | 2.87 Mn |
| Mar 31, 2025 | 1.92 Mn |
| Dec 31, 2024 | 1.39 Mn |
| Sep 30, 2024 | 1.93 Mn |
| Jun 30, 2024 | 3.20 Mn |
| Mar 31, 2024 | 105,000.00 |
| Dec 31, 2023 | 4.01 Mn |
| Sep 30, 2023 | 4.40 Mn |
| Jun 30, 2023 | 4.62 Mn |
| Mar 31, 2023 | 25,000.00 |
| Dec 31, 2022 | 3.23 Mn |
| Sep 30, 2022 | 3.32 Mn |
| Jun 30, 2022 | 3.79 Mn |
| Mar 31, 2022 | 620,000.00 |
| Dec 31, 2021 | 3.23 Mn |
| Sep 30, 2021 | 3.52 Mn |
| Jun 30, 2021 | 3.51 Mn |
| Mar 31, 2021 | 3.22 Mn |